You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
醫療器械及醫藥股普遍逆市捱沽 微創(00853.HK)愛康(01789.HK)挫逾一成
阿思達克 10-19 14:48
醫療器械及醫藥股今天逆市下跌,尤其是微創醫療(00853.HK)三連跌,今天股價一舉跌破20天、10天及50天線(31.5-32.6元),最低見29.05元,現造29.25元,續挫10.6%,成交急增至2,249萬股,涉資6.74億元。愛康醫療(01789.HK)失守20天、10天及100天線(20.8元、21.8元及22.2元),最低見20.05元,現造20.3元,急吐11%,成交增至609萬股。

海吉亞醫療(06078.HK)四連跌兼失守10天線(48.7元),最低見46.3元,現造46.4元,續跌6.1%。康基醫療(09997.HK)反覆吐5.9%,報21.65元,股價失守20天及10天線(21.75元及22.2元)。

復生醫藥(02196.HK)、藍籌藥明生物(02269.HK)/石藥集團(01093.HK)、藥明康德(02359.HK)、聯邦製藥(03933.HK)及威高股份(01066.HK)也跌逾2%-4%,後者沽壓最大,股價失守20天線(15.85元),最低見14.72元,創四個月低,現造15.22元,跌4.5%。

國家組織高值醫用耗材聯合採購辦公室上周五(16日)正式發佈《國家組織冠脈支架集中帶量採購文件》,是迄今為止第一個在國家層面進行的高值耗材帶量採購項目,顯示在藥品國家集採常態化後,醫療器械市場也迎來集採,產品價格有望大幅下調,相關公司業績或受到影響。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account